Home > Insider Trading > Filing (0001140361-17-047821)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1358762	Reata Pharmaceuticals Inc	RETA	Pharmaceutical Preparations (2834)	113651945

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1372218	Cpmg Inc	2000 Mckinney Ave, Ste 2125 Dallas TX 75201		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2017-12-29	17,000	$28.47	44,200	No	4	P	Indirect	By Barred Owl Partners, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Barred Owl Partners, LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	34,897	Indirect	By Managed Account for Trustees of the University of Pennsylvania
Class A Common Stock	442,560	Indirect	By Gallopavo, LP
Class A Common Stock	748,253	Indirect	By Roadrunner Fund, LP
Class A Common Stock	103,185	Indirect	By Blackwell Partners LLC
Class A Common Stock	431,155	Indirect	By Yellow Warbler, LP
Class A Common Stock	110,640	Indirect	By Killdeer Fund, LP
Class A Common Stock	109,415	Indirect	By Mallard Fund, LP
Class A Common Stock	280,500	Indirect	By Willet Fund, LP
Class A Common Stock	37,909	Indirect	By Crested Crane, LP
Class A Common Stock	63,481	Indirect	By Flamingo Fund, LP
Class A Common Stock	334,740	Indirect	By Sandpiper Fund, LP
Class A Common Stock	160,265	Indirect	By Kestrel Fund, LP
Class A Common Stock	11,076	Indirect	By CD Fund, LP
Class A Common Stock	134	Indirect	By Redbird Life Sciences Partners, LP
Class A Common Stock	113	Direct

Footnotes

This price reflects the weighted average purchase price for open-market purchases on December 29, 2017, within a $1.00 range. The actual prices for these transactions range from $28.40 to $28.50 inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.